EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Estimating the effect of diuretics and inhaled corticosteroids for evolving bronchopulmonary dysplasia in preterm infants

Jonathan L Slaughter iD, Mark A Klebanoff iD, Erinn M Hade iD

Paediatric and Perinatal Epidemiology · 2024

DOI: 10.1111/ppe.13038 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Paediatric and Perinatal Epidemiology, 2024. Verfasst von Jonathan L Slaughter und 2 weiteren Autor:innen. Beteiligte Einrichtung: Center for Perinatal Research, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Bronchopulmonary Dysplasia, Diuretics, Adrenal Cortex Hormones, Infant, Extremely Premature. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Heart, Lung, and Blood Institute, National Institutes of Health, NHLBI NIH HHS, NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Off‐label treatment of extremely preterm infants with diuretics and inhaled corticosteroids (ICS) for evolving bronchopulmonary dysplasia (BPD) is common. Their effectiveness in reducing mortality or BPD severity, and optimal treatment timing, are unclear.

Objectives

To determine whether diuretic treatment or ICS administration for infants with early evolving (between 10–27 days postnatal) and progressively evolving (28th‐day–36th‐week postnatal) BPD are independently associated with reduced mortality and moderate or severe BPD at 36‐weeks postmenstrual age (PMA).

Methods

We examined neonates born before 28 weeks' gestation and admitted to neonatal intensive care units on postnatal Day 0 between 2006 and 2016 using data collected during routine care recorded within the Paediatric Health Information System (PHIS). An early evolving BPD cohort consisted of infants treated with oxygen, positive pressure or mechanical ventilation at 10 days postnatal. The progressively evolving BPD cohort consisted of infants treated with these modalities at 28 days. In new users, we evaluated the effect of diuretic and ICS treatment on mortality or BPD severity at 36 weeks PMA, adjusting for time‐dependent confounding by respiratory status using marginal structural models.

Results

Early evolving BPD was present in 10,135 patients; progressively evolving BPD in 11,728. New diuretic exposure during early evolving BPD (adjusted risk ratio [aRR] 0.77, 95% confidence interval [CI] 0.65, 0.93) was associated with decreased mortality or moderate/severe BPD risk. New diuretics (aRR 0.86, 95% CI 0.75, 0.99) during progressively evolving BPD between 28‐days–36‐weeks PMA were less strongly associated with mortality or moderate/severe BPD reduction. There was no strong association for ICS in patients with early evolving (aRR: 1.40; 95% CI: 0.79, 2.51) or progressively evolving BPD (aRR 1.16, 95% CI 0.95, 1.49).

Conclusion

Diuretics, but not ICS, for evolving BPD were associated with mortality and BPD risk reduction.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Bronchopulmonary DysplasiaDiureticsAdrenal Cortex HormonesInfant, Extremely PrematureHumansInfant, NewbornFemaleAdministration, InhalationMaleGestational AgeInfant, PrematureIntensive Care Units, NeonatalRespiration, ArtificialInfant

Stichwörter der Autor:innen

bronchopulmonary dysplasiadiureticsinhaled corticosteroidneonatepharmacoepidemiologypreterm birth

Substanzen

DiureticsAdrenal Cortex Hormones

Autor:innen und Institutionen

  • Center for Perinatal Research, The Research Institute at Nationwide Children's Hospital, Columbus, Ohio, USA.
  • Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, USA.
  • Division of Epidemiology, College of Public Health, The Ohio State University, Columbus, Ohio, USA.
  • Division of Obstetrics and Gynecology, The Ohio State University College of Medicine, Columbus, Ohio, USA.
  • Division of Biostatistics, Department of Population Health, New York University Grossman School of Medicine, New York, New York, USA.

ORCID-Profile: Jonathan L Slaughter, Mark A Klebanoff, Erinn M Hade

Förderung

  • National Heart, Lung, and Blood Institute, National Institutes of Health
  • NHLBI NIH HHS
  • NIH HHS
  • NINDS NIH HHS

Zitieren

APA

Slaughter, J. L., Klebanoff, M. A., & Hade, E. M. (2024). Estimating the effect of diuretics and inhaled corticosteroids for evolving bronchopulmonary dysplasia in preterm infants. Paediatric and Perinatal Epidemiology. https://doi.org/10.1111/ppe.13038

Vancouver

Slaughter JL, Klebanoff MA, Hade EM. Estimating the effect of diuretics and inhaled corticosteroids for evolving bronchopulmonary dysplasia in preterm infants. Paediatric and Perinatal Epidemiology. 2024. doi:10.1111/ppe.13038

BibTeX
@article{Slaughter2024,
  author = {Slaughter, Jonathan L and Klebanoff, Mark A and Hade, Erinn M},
  title = {Estimating the effect of diuretics and inhaled corticosteroids for evolving bronchopulmonary dysplasia in preterm infants},
  journal = {Paediatric and Perinatal Epidemiology},
  year = {2024},
  doi = {10.1111/ppe.13038}
}
Kostenlos starten →